Předmět: |
|
Zdroj: |
Drug Week; 3/31/2023, p2601-2601, 1p |
Abstrakt: |
Recent advancements in genetic sequencing technologies have allowed for more accurate detection of mtDNA mutations and other mitochondrial abnormalities, leading to earlier diagnosis and intervention in patients with metabolic syndrome. Keywords: Diseases and Conditions; Drugs and Therapies; Health and Medicine; Healthcare; Metabolic Syndrome; Nutritional and Metabolic Diseases and Conditions; Pharmaceuticals; Risk and Prevention; Technology EN Diseases and Conditions Drugs and Therapies Health and Medicine Healthcare Metabolic Syndrome Nutritional and Metabolic Diseases and Conditions Pharmaceuticals Risk and Prevention Technology 2601 2601 1 03/27/23 20230331 NES 230331 2023 MAR 31 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Current study results on metabolic syndrome have been published. [Extracted from the article] |
Databáze: |
Complementary Index |
Externí odkaz: |
|